AU2008313622A1 - Solid dispersion product of N-aryl urea-based drugs - Google Patents
Solid dispersion product of N-aryl urea-based drugs Download PDFInfo
- Publication number
- AU2008313622A1 AU2008313622A1 AU2008313622A AU2008313622A AU2008313622A1 AU 2008313622 A1 AU2008313622 A1 AU 2008313622A1 AU 2008313622 A AU2008313622 A AU 2008313622A AU 2008313622 A AU2008313622 A AU 2008313622A AU 2008313622 A1 AU2008313622 A1 AU 2008313622A1
- Authority
- AU
- Australia
- Prior art keywords
- group
- phenyl
- amino
- alkyl
- urea
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US99961807P | 2007-10-19 | 2007-10-19 | |
US60/999,618 | 2007-10-19 | ||
PCT/EP2008/064076 WO2009050291A2 (en) | 2007-10-19 | 2008-10-17 | Solid dispersion product of n-aryl urea-based drugs |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2008313622A1 true AU2008313622A1 (en) | 2009-04-23 |
Family
ID=40089463
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2008313622A Abandoned AU2008313622A1 (en) | 2007-10-19 | 2008-10-17 | Solid dispersion product of N-aryl urea-based drugs |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP2197425A2 (es) |
JP (1) | JP2011500649A (es) |
KR (1) | KR20100087170A (es) |
CN (1) | CN101827584A (es) |
AU (1) | AU2008313622A1 (es) |
BR (1) | BRPI0818340A2 (es) |
CA (1) | CA2699301A1 (es) |
CO (1) | CO6270206A2 (es) |
CR (1) | CR11442A (es) |
DO (1) | DOP2010000117A (es) |
EC (1) | ECSP10010183A (es) |
GT (1) | GT201000102A (es) |
MX (1) | MX2010004291A (es) |
PA (1) | PA8800101A1 (es) |
RU (1) | RU2010119929A (es) |
UA (1) | UA100865C2 (es) |
WO (1) | WO2009050291A2 (es) |
ZA (1) | ZA201002095B (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009100176A2 (en) * | 2008-02-07 | 2009-08-13 | Abbott Laboratories | Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor |
JO3002B1 (ar) | 2009-08-28 | 2016-09-05 | Irm Llc | مركبات و تركيبات كمثبطات كيناز بروتين |
MX2012014387A (es) * | 2010-06-09 | 2013-05-01 | Abbvie Inc | Dispersiones solidas que contienen inhibidores de cinasa. |
CN103917236A (zh) | 2011-11-11 | 2014-07-09 | 诺华股份有限公司 | 治疗增生性疾病的方法 |
LT2782557T (lt) | 2011-11-23 | 2018-12-27 | Array Biopharma, Inc. | Farmacinės kompozicijos |
WO2014003678A1 (en) * | 2012-06-28 | 2014-01-03 | Xspray Microparticles Ab | Pharmaceutical compositions comprising ambrisentan and solid dispersion particles containing tadalafil |
WO2014003677A1 (en) * | 2012-06-28 | 2014-01-03 | Xspray Microparticles Ab | Pharmaceutical compositions comprising solid dispersion particles containing tadalafil |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1959926A1 (en) * | 2005-10-25 | 2008-08-27 | Abbott Laboratories | Formulation comprising a drug of low water solubility and method of use thereof |
WO2007066189A2 (en) * | 2005-12-09 | 2007-06-14 | Pfizer Products Inc. | Salts, prodrugs and formulations of 1-[5-(4-amino-7-isopropyl-7h-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-2-methoxy-phenyl]-3-(2,4-dichloro-phenyl)-urea |
CA2667720A1 (en) * | 2006-11-09 | 2008-05-15 | Abbott Gmbh & Co. Kg. | Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor |
-
2008
- 2008-10-17 RU RU2010119929/15A patent/RU2010119929A/ru not_active Application Discontinuation
- 2008-10-17 EP EP08839333A patent/EP2197425A2/en not_active Withdrawn
- 2008-10-17 KR KR1020107010979A patent/KR20100087170A/ko not_active Application Discontinuation
- 2008-10-17 AU AU2008313622A patent/AU2008313622A1/en not_active Abandoned
- 2008-10-17 JP JP2010529408A patent/JP2011500649A/ja active Pending
- 2008-10-17 PA PA20088800101A patent/PA8800101A1/es unknown
- 2008-10-17 CN CN200880112150A patent/CN101827584A/zh active Pending
- 2008-10-17 UA UAA201006029A patent/UA100865C2/ru unknown
- 2008-10-17 WO PCT/EP2008/064076 patent/WO2009050291A2/en active Application Filing
- 2008-10-17 BR BRPI0818340 patent/BRPI0818340A2/pt not_active IP Right Cessation
- 2008-10-17 CA CA2699301A patent/CA2699301A1/en not_active Abandoned
- 2008-10-17 MX MX2010004291A patent/MX2010004291A/es not_active Application Discontinuation
-
2010
- 2010-03-24 ZA ZA2010/02095A patent/ZA201002095B/en unknown
- 2010-04-16 GT GT201000102A patent/GT201000102A/es unknown
- 2010-04-16 DO DO2010000117A patent/DOP2010000117A/es unknown
- 2010-04-27 CO CO10049271A patent/CO6270206A2/es not_active Application Discontinuation
- 2010-05-17 EC EC2010010183A patent/ECSP10010183A/es unknown
- 2010-05-19 CR CR11442A patent/CR11442A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CO6270206A2 (es) | 2011-04-20 |
WO2009050291A2 (en) | 2009-04-23 |
PA8800101A1 (es) | 2009-05-15 |
GT201000102A (es) | 2012-03-12 |
JP2011500649A (ja) | 2011-01-06 |
UA100865C2 (ru) | 2013-02-11 |
ECSP10010183A (es) | 2010-06-29 |
DOP2010000117A (es) | 2010-05-15 |
CA2699301A1 (en) | 2009-04-23 |
ZA201002095B (en) | 2011-11-30 |
EP2197425A2 (en) | 2010-06-23 |
RU2010119929A (ru) | 2011-11-27 |
CN101827584A (zh) | 2010-09-08 |
CR11442A (es) | 2010-09-06 |
BRPI0818340A2 (pt) | 2015-04-22 |
KR20100087170A (ko) | 2010-08-03 |
MX2010004291A (es) | 2010-08-02 |
WO2009050291A3 (en) | 2010-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2008313622A1 (en) | Solid dispersion product of N-aryl urea-based drugs | |
RU2728824C1 (ru) | Препарат активатора глюкокиназы для перорального введения и способ его получения | |
US20090143423A1 (en) | Solid dispersion product containing n-aryl urea-based compound | |
US10493161B2 (en) | Solution for spray drying comprising hypromellose acetate succinate and method for producing solid dispersion | |
BRPI0715712B1 (pt) | Composição farmacêutica adequada para a administração oral compreendendo um derivado de triazol[4,5d]pirimidina | |
KR20120109522A (ko) | 시그마 수용체 리간드들을 포함하는 약학 조성물들 | |
JP2003503380A (ja) | 無定形硝酸エステルおよびその製剤組成物 | |
WO2002040054A1 (fr) | Preparation pharmaceutique contenant de la copolyvidone | |
KR100522239B1 (ko) | 아세트아미노펜을 함유하는 제어방출성의 경구용 제제 | |
TW202216117A (zh) | 經口用醫藥組成物及其製造方法 | |
JP2001511796A (ja) | 環状四級アンモニウム化合物を経口投与するための乾燥形態の薬学的調合剤 | |
JP2003527424A (ja) | オキサゾリジノン錠剤製剤 | |
CN107072954B (zh) | 用于口服给药的包含洛贝格列酮的药物组合物 | |
KR100912196B1 (ko) | Ltb4 길항제를 함유하는 약제학적 제형 | |
WO2020122244A1 (ja) | 錠剤及びその製造方法 | |
JP2002212063A (ja) | コポリビドン含有製剤 | |
EP4076407B1 (en) | A pharmaceutical composition of a pyrazole compound dispersed in a polymer matrix | |
US20240216347A1 (en) | Bezuclastinib formulations | |
KR20190050784A (ko) | 테소펜신 조성물 | |
WO2021006267A1 (ja) | ピラゾール誘導体の塩及びピラゾール誘導体の製剤 | |
JP2024091760A (ja) | 非晶質固体分散体を含む複合物 | |
JP5106119B2 (ja) | シクロオキシゲナーゼ−2阻害剤を含む経口投与用の薬剤、およびその調製方法 | |
RU2261095C1 (ru) | Лекарственная форма, обладающая нестероидным противовоспалительным действием, и способ ее изготовления | |
CN106456612A (zh) | 经口给药用医药组合物 | |
JPWO2020246526A1 (ja) | キサンチンオキシダーゼ阻害剤含有腸溶性製剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |